What does CUSIP 92764N102 represent in this 13F holders report?

CUSIP 92764N102 is the security identifier for VIR - Vir Biotechnology, Inc. - Common Stock, $0.0001 par value used to aggregate holder disclosures.

How many institutions held VIR - Vir Biotechnology, Inc. - Common Stock, $0.0001 par value in Q2 2022?

201 institutional investors reported VIR - Vir Biotechnology, Inc. - Common Stock, $0.0001 par value for Q2 2022. Use the holders table for investor-level position and value details.

Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (VIR)

CUSIP: 92764N102

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common Stock, $0.0001 par value
Shares outstanding: 168,432,200
Total 13F shares: 86,086,454
Share change: +5,735,503
Total reported value: $2,193,070,491
Put/Call ratio: 82%
Price per share: $25.47
Number of holders: 201
Value change: +$146,002,800
Number of buys: 121
Number of sells: 94

Quarterly Holders Quick Answers

What is CUSIP 92764N102?
CUSIP 92764N102 identifies VIR - Vir Biotechnology, Inc. - Common Stock, $0.0001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 92764N102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of VIR - Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
SB INVESTMENT ADVISERS (UK) LTD	13F	Company	13%	22,216,644	$571,412,000	—	31 Mar 2022	13F
VANGUARD GROUP INC	13F	Company	4.6%	7,758,397	$199,546,000	—	31 Mar 2022	13F
Temasek Holdings (Private) Ltd	13F	Company	3.3%	5,602,553	$144,097,663	—	31 Mar 2022	13F
BlackRock Finance, Inc.	13F	Company	3.2%	5,396,184	$138,790,000	—	31 Mar 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	2.8%	4,748,194	$122,124,000	—	31 Mar 2022	13F
Capital International Investors	13F	Company	2.6%	4,329,516	$111,355,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	2.5%	4,193,764	$107,864,000	—	31 Mar 2022	13F
BAILLIE GIFFORD & CO	13F	Company	2.3%	3,947,160	$101,521,000	—	31 Mar 2022	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	1.8%	3,091,105	$79,503,000	—	31 Mar 2022	13F
Alaska Permanent Fund Corp	13F	Company	1.4%	2,300,000	$59,156,000	—	31 Mar 2022	13F
Gates Foundation	13F	Company	0.93%	1,559,142	$40,100,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.74%	1,245,391	$32,031,000	—	31 Mar 2022	13F
Avidity Partners Management LP	13F	Company	0.46%	780,000	$20,062,000	—	31 Mar 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.47%	790,664	$20,028,000	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.44%	745,328	$19,170,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.37%	617,750	$15,889,000	—	31 Mar 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.36%	612,336	$15,749,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	0.36%	611,327	$15,724,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	0.35%	591,678	$15,218,000	—	31 Mar 2022	13F
NORGES BANK	13F	Company	0.33%	553,117	$14,226,169	—	31 Mar 2022	13F
Taikang Asset Management (Hong Kong) Co Ltd	13F	Company	0.32%	533,332	$13,717,000	—	31 Mar 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.3%	501,176	$12,890,000	—	31 Mar 2022	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.27%	450,363	$11,583,000	—	31 Mar 2022	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.2%	342,178	$8,801,000	—	31 Mar 2022	13F
Qube Research & Technologies Ltd	13F	Company	0.2%	328,914	$8,460,000	—	31 Mar 2022	13F
UBS Group AG	13F	Company	0.19%	321,053	$8,258,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	0.16%	274,503	$7,060,000	—	31 Mar 2022	13F
Rafferty Asset Management, LLC	13F	Company	0.15%	244,837	$6,297,000	—	31 Mar 2022	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.14%	229,301	$5,898,000	—	31 Mar 2022	13F
Nan Fung Group Holdings Ltd	13F	Company	0.13%	210,563	$5,416,000	—	31 Mar 2022	13F
CAPITAL FUND MANAGEMENT S.A.	13F	Company	0.12%	206,915	$5,321,853	—	31 Mar 2022	13F
Ergoteles LLC	13F	Company	0.11%	183,447	$4,718,000	—	31 Mar 2022	13F
CLARK ESTATES INC/NY	13F	Company	0.11%	180,000	$4,630,000	—	31 Mar 2022	13F
Man Group plc	13F	Company	0.1%	166,391	$4,280,000	—	31 Mar 2022	13F
Cubist Systematic Strategies, LLC	13F	Company	0.1%	160,503	$4,128,000	—	31 Mar 2022	13F
NORDEA INVESTMENT MANAGEMENT AB	13F	Company	0.09%	151,535	$3,990,000	—	31 Mar 2022	13F
Swiss National Bank	13F	Company	0.09%	154,700	$3,979,000	—	31 Mar 2022	13F
ClariVest Asset Management LLC	13F	Company	0.09%	143,717	$3,696,000	—	31 Mar 2022	13F
Allspring Global Investments Holdings, LLC	13F	Company	0.08%	134,573	$3,461,000	—	31 Mar 2022	13F
JANE STREET GROUP, LLC	13F	Company	0.08%	130,621	$3,360,000	—	31 Mar 2022	13F
BOULDER HILL CAPITAL MANAGEMENT LP	13F	Company	0.08%	126,900	$3,264,000	—	31 Mar 2022	13F
Squarepoint Ops LLC	13F	Company	0.07%	119,208	$3,066,000	—	31 Mar 2022	13F
Bank Julius Baer & Co. Ltd, Zurich	13F	Company	0.07%	116,750	$3,003,000	—	31 Mar 2022	13F
Ensign Peak Advisors, Inc	13F	Company	0.07%	113,509	$2,919,000	—	31 Mar 2022	13F
NATIXIS	13F	Company	0.07%	112,659	$2,898,000	—	31 Mar 2022	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.07%	109,570	$2,818,000	—	31 Mar 2022	13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	13F	Company	0.06%	105,128	$2,704,000	—	31 Mar 2022	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.06%	101,200	$2,603,000	—	31 Mar 2022	13F
BARCLAYS PLC	13F	Company	0.06%	100,891	$2,595,000	—	31 Mar 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.06%	94,400	$2,428,000	—	31 Mar 2022	13F

Institutional Holders of Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (VIR) as of Q2 2022

As of 30 Jun 2022, Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (VIR) was held by 201 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 86,086,454 shares. The largest 10 holders included SB INVESTMENT ADVISERS (UK) LTD, BlackRock Inc., VANGUARD GROUP INC, Temasek Holdings (Private) Ltd, STATE STREET CORP, BAILLIE GIFFORD & CO, ALLIANCEBERNSTEIN L.P., Capital International Investors, Alaska Permanent Fund Corp, and Bill & Melinda Gates Foundation. This page lists 202 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

191

Q2 2022 holders

201

Holder diff

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.